Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 13403 | 840 | 22.7 | 55% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 275 | 3 | NSAIDS//CYCLOOXYGENASE//CYCLOOXYGENASE 2 | 43399 |
| 466 | 2 | NSAIDS//NON STEROIDAL ANTI INFLAMMATORY DRUGS//COX 2 INHIBITORS | 15930 |
| 13403 | 1 | ACECLOFENAC//ETHAMSYLATE//MEFENAMIC ACID | 840 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | ACECLOFENAC | authKW | 688239 | 7% | 31% | 62 |
| 2 | ETHAMSYLATE | authKW | 549783 | 3% | 69% | 22 |
| 3 | MEFENAMIC ACID | authKW | 425263 | 7% | 21% | 56 |
| 4 | DICLOFENAC | authKW | 208238 | 12% | 6% | 97 |
| 5 | 4 HYDROXY ACECLOFENAC | authKW | 181751 | 1% | 100% | 5 |
| 6 | DICLOFENAC SODIUM | authKW | 179866 | 7% | 9% | 55 |
| 7 | DICLOFENAC SODIUM DETERMINATION | authKW | 145401 | 0% | 100% | 4 |
| 8 | ETAMSYLATE | authKW | 145397 | 1% | 67% | 6 |
| 9 | 4 HYDROXY DICLOFENAC | authKW | 109051 | 0% | 100% | 3 |
| 10 | CAS 15307 86 5 | authKW | 90870 | 1% | 50% | 5 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Chemistry, Analytical | 8012 | 42% | 0% | 352 |
| 2 | Pharmacology & Pharmacy | 2992 | 36% | 0% | 300 |
| 3 | Biochemical Research Methods | 1136 | 13% | 0% | 109 |
| 4 | Rheumatology | 485 | 5% | 0% | 39 |
| 5 | Chemistry, Medicinal | 445 | 8% | 0% | 63 |
| 6 | Chemistry, Multidisciplinary | 265 | 14% | 0% | 119 |
| 7 | Medicine, Research & Experimental | 88 | 5% | 0% | 42 |
| 8 | Medicine, General & Internal | 70 | 6% | 0% | 50 |
| 9 | Electrochemistry | 64 | 3% | 0% | 25 |
| 10 | Spectroscopy | 28 | 2% | 0% | 19 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | ANALYT DEV QUIMIOMETRY LADAQ | 36350 | 0% | 100% | 1 |
| 2 | CROM PESQUISAS CROMATOLG LIQUIDA | 36350 | 0% | 100% | 1 |
| 3 | ESTUDIOS SUPER CUAUTITLAN SECC QUIM ANALIT | 36350 | 0% | 100% | 1 |
| 4 | FARMCATEDRA ESNAYO VALORAC MEDICAMENTOS | 36350 | 0% | 100% | 1 |
| 5 | GIFU PREF POLICE HQ | 36350 | 0% | 100% | 1 |
| 6 | METHOD DEV RUMENTAL SERV | 36350 | 0% | 100% | 1 |
| 7 | PHARM ANHEMBI MORUMBI | 36350 | 0% | 100% | 1 |
| 8 | QUIMIOMETRIA QUIM ANALITLAQQA | 36350 | 0% | 100% | 1 |
| 9 | RC PATEL PHARM | 36350 | 0% | 100% | 1 |
| 10 | UNITAT FIS QUIM | 36350 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS | 8263 | 6% | 0% | 50 |
| 2 | JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS | 5336 | 3% | 1% | 23 |
| 3 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 4711 | 3% | 1% | 25 |
| 4 | CLINICAL TRIALS JOURNAL | 3674 | 1% | 2% | 6 |
| 5 | JOURNAL OF LIQUID CHROMATOGRAPHY | 3301 | 2% | 1% | 18 |
| 6 | WOMANS ART JOURNAL | 2889 | 0% | 3% | 3 |
| 7 | ANALYTICAL LETTERS | 2609 | 3% | 0% | 22 |
| 8 | ANALYTICAL LETTERS PART B-CLINICAL AND BIOCHEMICAL ANALYSIS | 2185 | 1% | 1% | 5 |
| 9 | JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2011 | 3% | 0% | 26 |
| 10 | INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS | 1807 | 2% | 0% | 14 |
Author Key Words |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | ACECLOFENAC | 688239 | 7% | 31% | 62 | Search ACECLOFENAC | Search ACECLOFENAC |
| 2 | ETHAMSYLATE | 549783 | 3% | 69% | 22 | Search ETHAMSYLATE | Search ETHAMSYLATE |
| 3 | MEFENAMIC ACID | 425263 | 7% | 21% | 56 | Search MEFENAMIC+ACID | Search MEFENAMIC+ACID |
| 4 | DICLOFENAC | 208238 | 12% | 6% | 97 | Search DICLOFENAC | Search DICLOFENAC |
| 5 | 4 HYDROXY ACECLOFENAC | 181751 | 1% | 100% | 5 | Search 4+HYDROXY+ACECLOFENAC | Search 4+HYDROXY+ACECLOFENAC |
| 6 | DICLOFENAC SODIUM | 179866 | 7% | 9% | 55 | Search DICLOFENAC+SODIUM | Search DICLOFENAC+SODIUM |
| 7 | DICLOFENAC SODIUM DETERMINATION | 145401 | 0% | 100% | 4 | Search DICLOFENAC+SODIUM+DETERMINATION | Search DICLOFENAC+SODIUM+DETERMINATION |
| 8 | ETAMSYLATE | 145397 | 1% | 67% | 6 | Search ETAMSYLATE | Search ETAMSYLATE |
| 9 | 4 HYDROXY DICLOFENAC | 109051 | 0% | 100% | 3 | Search 4+HYDROXY+DICLOFENAC | Search 4+HYDROXY+DICLOFENAC |
| 10 | CAS 15307 86 5 | 90870 | 1% | 50% | 5 | Search CAS+15307+86+5 | Search CAS+15307+86+5 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | GOUDA, AA , EL-SAYED, MIK , AMIN, AS , EL SHEIKH, R , (2013) SPECTROPHOTOMETRIC AND SPECTROFLUOROMETRIC METHODS FOR THE DETERMINATION OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS: A REVIEW.ARABIAN JOURNAL OF CHEMISTRY. VOL. 6. ISSUE 2. P. 145-163 | 54 | 55% | 11 |
| 2 | DAVIES, NM , ANDERSON, KE , (1997) CLINICAL PHARMACOKINETICS OF DICLOFENAC - THERAPEUTIC INSIGHTS AND PITFALLS.CLINICAL PHARMACOKINETICS. VOL. 33. ISSUE 3. P. 184-213 | 67 | 52% | 155 |
| 3 | YILMAZ, B , KABAN, S , AKCAY, BK , CILTAS, U , (2015) DIFFERENTIAL PULSE VOLTAMMETRIC DETERMINATION OF DICLOFENAC IN PHARMACEUTICAL PREPARATIONS AND HUMAN SERUM.BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES. VOL. 51. ISSUE 2. P. 285 -294 | 26 | 84% | 1 |
| 4 | EMARA, LH , TAHA, NF , EL-ASHMAWY, AA , RASLAN, HM , MURSI, NM , (2012) A RAPID AND SENSITIVE BIOANALYTICAL HPLC METHOD FOR DETERMINING DICLOFENAC SODIUM IN HUMAN PLASMA FOR BIOEQUIVALENCE STUDIES.JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES. VOL. 35. ISSUE 15. P. 2203-2216 | 23 | 88% | 5 |
| 5 | TUBINO, M , DE SOUZA, RL , (2005) GRAVIMETRIC METHOD FOR THE DETERMINATION OF DICLOFENAC IN PHARMACEUTICAL PREPARATIONS.JOURNAL OF AOAC INTERNATIONAL. VOL. 88. ISSUE 6. P. 1684-1687 | 26 | 90% | 15 |
| 6 | AFRASIABI, M , KIANIPOUR, S , ZAD, ZR , BABEI, A , (2013) APPLICATION OF MULTI-WALLED CARBON NANOTUBES MODIFIED GLASSY CARBON ELECTRODE FOR DETERMINATION OF MEFENAMIC ACID IN PHARMACEUTICAL PREPARATIONS AND BIOLOGICAL FLUIDS.JOURNAL OF THE CHEMICAL SOCIETY OF PAKISTAN. VOL. 35. ISSUE 4. P. 1113-1121 | 29 | 66% | 1 |
| 7 | DE SOUZA, RL , TUBINO, M , (2005) SPECTROPHOTOMETRIC DETERMINATION OF DICLOFENAC IN PHARMACEUTICAL PREPARATIONS.JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY. VOL. 16. ISSUE 5. P. 1068-1073 | 26 | 87% | 21 |
| 8 | BAE, SK , KIM, SH , LEE, HW , SEONG, SJ , SHIN, SY , LEE, SH , LIM, MS , YOON, YR , LEE, HJ , (2012) PHARMACOKINETICS OF A NEW ONCE-DAILY CONTROLLED-RELEASE FORMULATION OF ACECLOFENAC IN KOREAN HEALTHY SUBJECTS COMPARED WITH IMMEDIATE-RELEASE ACECLOFENAC AND THE EFFECT OF FOOD A RANDOMIZED, OPEN-LABEL, THREE-PERIOD, CROSSOVER, SINGLE-CENTRE STUDY.CLINICAL DRUG INVESTIGATION. VOL. 32. ISSUE 2. P. 111-119 | 21 | 91% | 1 |
| 9 | CHEEMALAPATI, S , KARUPPIAH, C , CHEN, SM , (2014) SYNTHESIS OF POLY-ANILINE/GRAPHENE NANO-COMPOSITE FILM FOR THE DETERMINATION OF NON-STEROIDAL ANTI-INFLAMMATORY DRUG (NSAIDS) DICLOFENAC IN BLOOD SERUM.SCIENCE OF ADVANCED MATERIALS. VOL. 6. ISSUE 8. P. 1760 -1768 | 26 | 68% | 2 |
| 10 | DOOLEY, M , SPENCER, CM , DUNN, CJ , (2001) ACECLOFENAC - A REAPPRAISAL OF ITS USE IN THE MANAGEMENT OF PAIN AND RHEUMATIC DISEASE.DRUGS. VOL. 61. ISSUE 9. P. 1351-1378 | 29 | 83% | 36 |
Classes with closest relation at Level 1 |